Delivery Order SPE2DB20D1100-SPE2DB24FD4D4

Award Date 8/22/24
Potential Completion Date 8/23/24
Potential Value $133K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,930.20, is for the supply of STELARA 90 MG/ML syringes. It is a firm fixed-price contract with an ultimate completion date of August 23, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC covers...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) for $999,999,999 that runs through November 2026. The delivery order is for STELARA 90 MG/ML syringes, a specialty medication, with a ceiling value of $16,656.55 and a completion date of November 21, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition....
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $11,743.23 firm fixed-price contract is for the supply of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) awarded by the DLA to Amerisourcebergen, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide STELARA 90 MG/ML syringes. The contract is a firm fixed-price delivery order with a ceiling value of $7,207.68 and an ultimate completion date of September 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) the DLA Troop Support Medical has with AmerisourceBergen, valued at up to $999,999,999 through December 2025,...
This is a firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $166,343.83, is for the provision of STELARA 90 MG/ML syringes. It has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract delivers STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product, with a ceiling value of $307,182.05 and a completion date of February 21, 2024. This delivery order is part of the DLA's broader efforts to provide essential pharmaceutical and medical supplies to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML SYRINGEML. The firm-fixed-price contract has a ceiling value of $7,735.40 and an ultimate completion date of August 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
This is a $61,930.93 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of STELARA 90 MG/ML syringes to support medical supply requirements. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical that provides a comprehensive range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $48,696.41, is for the delivery of STELARA 90 MG/ML syringes. It is a firm fixed price contract with a period of performance through February 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML syringes. The delivery order, valued at $15,667.56, has a firm fixed price and an ultimate completion date of July 17, 2024. It is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD4D4
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $133,487.23 firm-fixed-price contract is for the supply of STELARA 90 MG/ML syringes, with a completion date of August 23, 2024.

Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to provide a wide range of pharmaceutical and medical products to support military treatment facilities, veterans' hospitals, and other government healthcare programs. This delivery order is fulfilled under one of those broader IDCs, enabling DLA to efficiently procure the necessary specialty medication from Amerisourcebergen. The contract does not have a set-aside designation.

Generated 11/21/24, 9:19 AM